Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carrier Proteins | 14 | 2023 | 673 | 3.700 |
Why?
|
| Cardiomyopathy, Hypertrophic | 5 | 2023 | 42 | 2.880 |
Why?
|
| Myocytes, Cardiac | 7 | 2023 | 275 | 2.080 |
Why?
|
| Sarcomeres | 8 | 2023 | 23 | 1.870 |
Why?
|
| Myofibrils | 3 | 2023 | 23 | 1.720 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2023 | 97 | 1.590 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2023 | 187 | 1.510 |
Why?
|
| Cytoskeletal Proteins | 2 | 2022 | 223 | 1.330 |
Why?
|
| Myocardial Contraction | 8 | 2023 | 244 | 1.210 |
Why?
|
| Myocardium | 8 | 2023 | 529 | 1.020 |
Why?
|
| Calcium | 6 | 2022 | 1156 | 0.950 |
Why?
|
| Cardiomyopathies | 3 | 2023 | 240 | 0.930 |
Why?
|
| Cardiac Conduction System Disease | 1 | 2022 | 7 | 0.860 |
Why?
|
| Dysferlin | 2 | 2021 | 13 | 0.850 |
Why?
|
| Excitation Contraction Coupling | 1 | 2021 | 5 | 0.810 |
Why?
|
| Muscle Proteins | 1 | 2021 | 132 | 0.760 |
Why?
|
| Haploinsufficiency | 2 | 2023 | 62 | 0.710 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2019 | 57 | 0.660 |
Why?
|
| Cardiotonic Agents | 1 | 2019 | 88 | 0.650 |
Why?
|
| Calpain | 1 | 2019 | 111 | 0.650 |
Why?
|
| Medical Laboratory Personnel | 1 | 2017 | 4 | 0.620 |
Why?
|
| Narration | 1 | 2017 | 16 | 0.620 |
Why?
|
| Membrane Proteins | 2 | 2021 | 1196 | 0.590 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2019 | 104 | 0.590 |
Why?
|
| Mentors | 1 | 2017 | 76 | 0.570 |
Why?
|
| Mutation | 9 | 2023 | 3968 | 0.560 |
Why?
|
| Heart Atria | 3 | 2023 | 250 | 0.530 |
Why?
|
| Muscle, Skeletal | 6 | 2022 | 450 | 0.530 |
Why?
|
| Mice | 18 | 2023 | 11356 | 0.510 |
Why?
|
| Animals | 27 | 2023 | 26590 | 0.510 |
Why?
|
| Myosins | 3 | 2023 | 90 | 0.460 |
Why?
|
| Biomedical Research | 1 | 2017 | 376 | 0.450 |
Why?
|
| Cell Membrane | 3 | 2021 | 666 | 0.410 |
Why?
|
| Phosphorylation | 7 | 2019 | 1106 | 0.410 |
Why?
|
| Myocardial Infarction | 4 | 2019 | 376 | 0.400 |
Why?
|
| Muscular Dystrophies | 2 | 2021 | 54 | 0.400 |
Why?
|
| Atrial Function | 2 | 2023 | 17 | 0.390 |
Why?
|
| Heterozygote | 3 | 2017 | 365 | 0.370 |
Why?
|
| Disease Progression | 1 | 2014 | 1532 | 0.360 |
Why?
|
| Annexin A6 | 3 | 2019 | 10 | 0.360 |
Why?
|
| Muscular Dystrophy, Animal | 3 | 2019 | 21 | 0.350 |
Why?
|
| Disease Models, Animal | 9 | 2023 | 2231 | 0.330 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 2 | 2019 | 14 | 0.310 |
Why?
|
| Heart Ventricles | 3 | 2017 | 760 | 0.300 |
Why?
|
| Glucocorticoids | 2 | 2022 | 352 | 0.300 |
Why?
|
| Heart Failure | 4 | 2020 | 1204 | 0.280 |
Why?
|
| Mice, 129 Strain | 3 | 2021 | 55 | 0.270 |
Why?
|
| Ventricular Remodeling | 2 | 2019 | 96 | 0.270 |
Why?
|
| Mice, Transgenic | 6 | 2019 | 1540 | 0.270 |
Why?
|
| Protein Isoforms | 2 | 2023 | 270 | 0.250 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2023 | 2271 | 0.250 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2021 | 30 | 0.240 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2019 | 318 | 0.230 |
Why?
|
| Muscle Fibers, Skeletal | 3 | 2019 | 45 | 0.230 |
Why?
|
| Humans | 17 | 2023 | 86658 | 0.220 |
Why?
|
| Caffeine | 1 | 2023 | 81 | 0.220 |
Why?
|
| Contactins | 1 | 2022 | 2 | 0.220 |
Why?
|
| Purkinje Fibers | 1 | 2022 | 27 | 0.210 |
Why?
|
| Tachycardia | 1 | 2022 | 35 | 0.210 |
Why?
|
| Protein Binding | 2 | 2023 | 1457 | 0.210 |
Why?
|
| Membrane Fusion | 1 | 2021 | 37 | 0.200 |
Why?
|
| Phenotype | 3 | 2017 | 2380 | 0.190 |
Why?
|
| Calcium-Binding Proteins | 1 | 2021 | 115 | 0.190 |
Why?
|
| Prednisone | 2 | 2022 | 258 | 0.190 |
Why?
|
| Proteolysis | 2 | 2019 | 100 | 0.190 |
Why?
|
| Sarcolemma | 5 | 2019 | 30 | 0.190 |
Why?
|
| Muscle Contraction | 1 | 2021 | 284 | 0.190 |
Why?
|
| Exons | 2 | 2019 | 450 | 0.190 |
Why?
|
| Fibrosis | 5 | 2021 | 203 | 0.190 |
Why?
|
| Sarcoglycans | 2 | 2019 | 13 | 0.180 |
Why?
|
| Mice, Knockout | 4 | 2019 | 1924 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 5 | 2017 | 3095 | 0.180 |
Why?
|
| Gene Editing | 1 | 2019 | 42 | 0.170 |
Why?
|
| Myotonic Dystrophy | 1 | 2019 | 7 | 0.170 |
Why?
|
| MyoD Protein | 1 | 2019 | 15 | 0.170 |
Why?
|
| Heart Function Tests | 1 | 2019 | 30 | 0.170 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2020 | 267 | 0.160 |
Why?
|
| Male | 13 | 2023 | 40985 | 0.160 |
Why?
|
| Ventricular Function | 1 | 2017 | 53 | 0.150 |
Why?
|
| Mice, Mutant Strains | 2 | 2016 | 229 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 937 | 0.150 |
Why?
|
| Homozygote | 1 | 2017 | 200 | 0.150 |
Why?
|
| Heart Conduction System | 1 | 2017 | 108 | 0.150 |
Why?
|
| Annexins | 1 | 2016 | 6 | 0.140 |
Why?
|
| Female | 10 | 2023 | 44547 | 0.140 |
Why?
|
| Dystrophin-Associated Protein Complex | 1 | 2015 | 3 | 0.140 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 1921 | 0.140 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2015 | 69 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2017 | 2819 | 0.130 |
Why?
|
| Echocardiography | 2 | 2017 | 911 | 0.130 |
Why?
|
| Electrocardiography | 1 | 2017 | 478 | 0.130 |
Why?
|
| Adaptation, Physiological | 1 | 2017 | 306 | 0.130 |
Why?
|
| Heart Rate | 1 | 2017 | 492 | 0.130 |
Why?
|
| Systole | 1 | 2014 | 129 | 0.120 |
Why?
|
| Protein Engineering | 1 | 2015 | 140 | 0.120 |
Why?
|
| Pressure | 1 | 2014 | 165 | 0.120 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 213 | 0.120 |
Why?
|
| Genetic Therapy | 1 | 2015 | 342 | 0.110 |
Why?
|
| Aorta | 1 | 2014 | 281 | 0.110 |
Why?
|
| Immunoassay | 1 | 2013 | 92 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 1 | 2014 | 217 | 0.110 |
Why?
|
| Actins | 1 | 2016 | 451 | 0.110 |
Why?
|
| Monocytes | 1 | 2014 | 216 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2015 | 448 | 0.110 |
Why?
|
| Heart | 2 | 2015 | 539 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 78 | 0.100 |
Why?
|
| Cardiomegaly | 1 | 2012 | 111 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2012 | 149 | 0.100 |
Why?
|
| Alleles | 1 | 2014 | 1128 | 0.100 |
Why?
|
| Serine | 1 | 2011 | 99 | 0.100 |
Why?
|
| Genotype | 1 | 2014 | 1852 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2012 | 445 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1384 | 0.080 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2022 | 120 | 0.080 |
Why?
|
| Middle Aged | 4 | 2020 | 25036 | 0.070 |
Why?
|
| Protein Transport | 2 | 2016 | 411 | 0.060 |
Why?
|
| Gene Expression | 2 | 2019 | 1284 | 0.060 |
Why?
|
| Epinephrine | 1 | 2023 | 84 | 0.060 |
Why?
|
| Calmodulin | 1 | 2023 | 50 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2020 | 1807 | 0.050 |
Why?
|
| Models, Biological | 1 | 2009 | 1749 | 0.050 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2021 | 4 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2019 | 1981 | 0.050 |
Why?
|
| Kinetics | 2 | 2014 | 1513 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2012 | 1221 | 0.050 |
Why?
|
| Muscles | 1 | 2021 | 194 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 262 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 301 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 128 | 0.040 |
Why?
|
| Dystrophin | 1 | 2019 | 21 | 0.040 |
Why?
|
| Muscle Development | 1 | 2019 | 41 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2019 | 129 | 0.040 |
Why?
|
| Point Mutation | 1 | 2019 | 246 | 0.040 |
Why?
|
| Mole Rats | 1 | 2017 | 4 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2019 | 142 | 0.040 |
Why?
|
| Rats | 3 | 2012 | 3992 | 0.040 |
Why?
|
| Mice, Inbred mdx | 1 | 2017 | 11 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 1015 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2017 | 148 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 296 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 104 | 0.040 |
Why?
|
| Muscular Atrophy | 1 | 2017 | 41 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 249 | 0.040 |
Why?
|
| Young Adult | 2 | 2020 | 5980 | 0.040 |
Why?
|
| Regeneration | 1 | 2017 | 143 | 0.030 |
Why?
|
| Dialysis Solutions | 1 | 1995 | 7 | 0.030 |
Why?
|
| Transcriptome | 1 | 2020 | 580 | 0.030 |
Why?
|
| Biomarkers | 2 | 2013 | 1719 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 280 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 134 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2015 | 27 | 0.030 |
Why?
|
| Protein Carbonylation | 1 | 2015 | 10 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1135 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 268 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 41 | 0.030 |
Why?
|
| Peritoneal Dialysis | 1 | 1995 | 32 | 0.030 |
Why?
|
| Base Sequence | 1 | 2019 | 2330 | 0.030 |
Why?
|
| Diaphragm | 1 | 2015 | 50 | 0.030 |
Why?
|
| Adolescent | 2 | 2020 | 8984 | 0.030 |
Why?
|
| Glutathione | 1 | 2015 | 104 | 0.030 |
Why?
|
| Arginine | 1 | 1995 | 136 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 916 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 82 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2015 | 205 | 0.030 |
Why?
|
| Renal Insufficiency | 1 | 1995 | 114 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2469 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2016 | 457 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 1995 | 278 | 0.030 |
Why?
|
| Wound Healing | 1 | 2016 | 344 | 0.030 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2013 | 6 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 928 | 0.030 |
Why?
|
| Electrochemical Techniques | 1 | 2013 | 8 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 557 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 736 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 294 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 2013 | 57 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2015 | 615 | 0.030 |
Why?
|
| Troponin I | 1 | 2013 | 27 | 0.030 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2015 | 306 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 248 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 493 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1621 | 0.030 |
Why?
|
| Myoblasts, Cardiac | 1 | 2012 | 1 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 1995 | 639 | 0.030 |
Why?
|
| Isoproterenol | 1 | 2012 | 59 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2014 | 679 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2019 | 1351 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2016 | 592 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 193 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 1098 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 663 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2011 | 72 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 488 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 107 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 599 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 339 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1753 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 18421 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 25658 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 1620 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 1991 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2357 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 5211 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 3243 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6513 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1995 | 45 | 0.010 |
Why?
|
| Mesenteric Arteries | 1 | 1995 | 29 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1995 | 711 | 0.010 |
Why?
|